117 related articles for article (PubMed ID: 26977254)
1. Advances in the Development and Validation of Test Methods in the United States.
Casey WM
Toxicol Res; 2016 Jan; 32(1):9-14. PubMed ID: 26977254
[TBL] [Abstract][Full Text] [Related]
2. A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).
Casey W; Jacobs A; Maull E; Matheson J; Clarke C; Lowit A
J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):170-3. PubMed ID: 25836963
[TBL] [Abstract][Full Text] [Related]
3. The US Federal Tox21 Program: A strategic and operational plan for continued leadership.
Thomas RS; Paules RS; Simeonov A; Fitzpatrick SC; Crofton KM; Casey WM; Mendrick DL
ALTEX; 2018; 35(2):163-168. PubMed ID: 29529324
[TBL] [Abstract][Full Text] [Related]
4. Intersection of toxicogenomics and high throughput screening in the Tox21 program: an NIEHS perspective.
Merrick BA; Paules RS; Tice RR
Int J Biotechnol; 2015; 14(1):7-27. PubMed ID: 27122658
[TBL] [Abstract][Full Text] [Related]
5. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
Stokes WS; Schechtman LM; Hill RN
Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
[TBL] [Abstract][Full Text] [Related]
6. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
Schechtman LM
ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
[TBL] [Abstract][Full Text] [Related]
7. An Integrated Chemical Environment to Support 21st-Century Toxicology.
Bell SM; Phillips J; Sedykh A; Tandon A; Sprankle C; Morefield SQ; Shapiro A; Allen D; Shah R; Maull EA; Casey WM; Kleinstreuer NC
Environ Health Perspect; 2017 May; 125(5):054501. PubMed ID: 28557712
[No Abstract] [Full Text] [Related]
8. Skin sensitization testing needs and data uses by US regulatory and research agencies.
Strickland J; Daniel AB; Allen D; Aguila C; Ahir S; Bancos S; Craig E; Germolec D; Ghosh C; Hudson NL; Jacobs A; Lehmann DM; Matheson J; Reinke EN; Sadrieh N; Vukmanovic S; Kleinstreuer N
Arch Toxicol; 2019 Feb; 93(2):273-291. PubMed ID: 30377734
[TBL] [Abstract][Full Text] [Related]
9. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
Kavlock R; Dix D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
[TBL] [Abstract][Full Text] [Related]
10. Elucidating environmental dimensions of neurological disorders and disease: Understanding new tools from federal chemical testing programs.
McPartland J; Dantzker H; Portier C
Sci Total Environ; 2017 Sep; 593-594():634-640. PubMed ID: 28364604
[TBL] [Abstract][Full Text] [Related]
11. Tox21 Enricher: Web-based Chemical/Biological Functional Annotation Analysis Tool Based on Tox21 Toxicity Screening Platform.
Hur J; Danes L; Hsieh JH; McGregor B; Krout D; Auerbach S
Mol Inform; 2018 May; 37(5):e1700129. PubMed ID: 29377626
[TBL] [Abstract][Full Text] [Related]
12. High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions.
Lynch C; Sakamuru S; Ooka M; Huang R; Klumpp-Thomas C; Shinn P; Gerhold D; Rossoshek A; Michael S; Casey W; Santillo MF; Fitzpatrick S; Thomas RS; Simeonov A; Xia M
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():191-209. PubMed ID: 37506331
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Computational Model for Androgen Receptor Activity.
Kleinstreuer NC; Ceger P; Watt ED; Martin M; Houck K; Browne P; Thomas RS; Casey WM; Dix DJ; Allen D; Sakamuru S; Xia M; Huang R; Judson R
Chem Res Toxicol; 2017 Apr; 30(4):946-964. PubMed ID: 27933809
[TBL] [Abstract][Full Text] [Related]
14. Using Tox21 High-Throughput Screening Assays for the Evaluation of Botanical and Dietary Supplements.
Hubbard TD; Hsieh JH; Rider CV; Sipes NS; Sedykh A; Collins BJ; Auerbach SS; Xia M; Huang R; Walker NJ; DeVito MJ
Appl In Vitro Toxicol; 2019 Mar; 5(1):10-25. PubMed ID: 30944845
[No Abstract] [Full Text] [Related]
15. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept.
Becker RA; Friedman KP; Simon TW; Marty MS; Patlewicz G; Rowlands JC
Regul Toxicol Pharmacol; 2015 Apr; 71(3):398-408. PubMed ID: 25656492
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the performance of selected (Q)SARs/expert systems for predicting acute oral toxicity.
Nelms MD; Karmaus AL; Patlewicz G
Comput Toxicol; 2020 Nov; 16():. PubMed ID: 33163737
[TBL] [Abstract][Full Text] [Related]
17. The ToxCast program for prioritizing toxicity testing of environmental chemicals.
Dix DJ; Houck KA; Martin MT; Richard AM; Setzer RW; Kavlock RJ
Toxicol Sci; 2007 Jan; 95(1):5-12. PubMed ID: 16963515
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the utility of a high throughput thiol-containing fluorescent probe to screen for reactivity: A case study with the Tox21 library.
Patlewicz G; Paul-Friedman K; Houck K; Zhang L; Huang R; Xia M; Brown J; Simmons SO
Comput Toxicol; 2023 May; 26():. PubMed ID: 37388277
[TBL] [Abstract][Full Text] [Related]
19. Validating new toxicology tests for regulatory acceptance.
Zeiger E; Stokes WS
Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):32-7. PubMed ID: 9629594
[TBL] [Abstract][Full Text] [Related]
20. Toxicity characterization of environmental chemicals by the US National Toxicology Program: an overview.
Chhabra RS; Bucher JR; Wolfe M; Portier C
Int J Hyg Environ Health; 2003 Aug; 206(4-5):437-45. PubMed ID: 12971699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
